Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.69 |
| ▸ | KDR | P35968 | 1/20 | 0.66 |
| ▸ | MMP13 | P45452 | 1/20 | 0.66 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.64 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.64 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.64 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.64 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.64 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.64 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.64 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.64 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.64 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.64 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | HPGDS | O60760 | 2/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29733373 | 1.00 | HTT (0.75) | HTTKMT2AKDRMMP13HDAC3 | |
| Hydrochloric Acid SCHEMBL27924615 | 0.98 | HTT (0.73) | HTTKMT2AKDRMMP13HDAC3 | |
| SCHEMBL7986921 | 0.90 | HTT (0.71) | HTTKMT2AKDRMMP13HDAC3 | |
| SCHEMBL1316772 | 0.90 | HTT (0.71) | HTTKMT2AKDRMMP13HDAC3 | |
| SCHEMBL4060215 | 0.89 | KMT2A (0.68) | HTTKMT2AKDRMMP13HDAC3 | |
| SCHEMBL3550399 | 0.87 | KMT2A (0.71) | HTTKMT2AKDRMMP13HDAC3 | |
| SCHEMBL27877038 | 0.87 | KMT2A (0.68) | HTTKMT2AHDAC3HDAC4HDAC1 | |
| SCHEMBL8373059 | 0.87 | KMT2A (0.67) | HTTKMT2AKDRHDAC3HDAC4 | |
| SCHEMBL18715392 | 0.87 | SMN1; SMN2 (0.68) | HTTKMT2AHDAC3HDAC4HDAC1 | |
| SCHEMBL29800992 | 0.86 | HTT (1.00) | HTTKMT2AMMP13HPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117924171-A | Phenanthrone derivative and synthesis method thereof | 华南理工大学 | 2024-04-26 | — | — | CN | claimed |
| CN-114890856-A | Method for synthesizing 2,2' -biphenyl-1-carboxylic acid derivative | 华南理工大学 | 2022-08-12 | — | — | CN | claimed |
| CN-104540825-B | Azaindole quinoline compound | 霍夫曼-拉罗奇有限公司 | 2017-10-24 | — | — | CN | claimed |
| US-4566899-A | Selective herbicidal benzylcarbamoylpyridine derivatives | RHONE-POULENC AGROCHIMIE (FR) | 1986-01-28 | — | — | US | claimed |
| EP-0112262-A1 | Benzylcarbamoylpyridine derivatives | RHONE-POULENC AGROCHIMIE (FR) | 1984-06-27 | — | — | EP | claimed |
| CN-117924171-A | Phenanthrone derivative and synthesis method thereof | 华南理工大学 | 2024-04-26 | — | — | CN | disclosed |
| CN-117187840-A | Method for electrochemically synthesizing pyridine carboxamide compound | 阜阳师范大学 | 2023-12-08 | — | — | CN | disclosed |
| CN-111808023-B | Method for preparing 3-aryl isoquinoline derivative | 四川大学 | 2022-10-21 | — | — | CN | disclosed |
| CN-114890856-A | Method for synthesizing 2,2' -biphenyl-1-carboxylic acid derivative | 华南理工大学 | 2022-08-12 | — | — | CN | disclosed |
| CN-111808023-A | Novel method for preparing 3-arylisoquinoline derivative | 四川大学 | 2020-10-23 | — | — | CN | disclosed |
| US-10759765-B2 | Heterocyclic carboxylic acid amide ligand and applications thereof in copper catalyzed coupling reaction of aryl halogeno substitute | CE PHARM CO., LTD. (CN) | 2020-09-01 | — | — | US | disclosed |
| US-20190127337-A1 | HETEROCYCLIC CARBOXYLIC ACID AMIDE LIGAND AND APPLICATIONS THEREOF IN COPPER CATALYZED COUPLING REACTION OF ARYL HALOGENO SUBSTITUTE | CE PHARM CO., LTD. (CN) | 2019-05-02 | — | — | US | disclosed |
| EP-0755374-A1 | PROCESS FOR PEPTIDE SEGMENT CONDENSATION | Merck & Co., Inc. (a New Jersey corp.) (US) | 1997-01-29 | — | — | EP | disclosed |
| US-5502165-A | AMIDATION OF CARBOXY COMPOOUND WITH AMINE IN WATER AND SOLVENT | MERCK & CO., INC. (US) | 1996-03-26 | — | — | US | disclosed |
| WO-1995027727-A2 | PROCESS FOR PEPTIDE SEGMENT CONDENSATION | MERCK & CO., INC. (US) | 1995-10-19 | — | — | WO | disclosed |
| WO-1995025101-A1 | PYRIDIL ETHYLATION OF LACTAMS | MERCK & CO., INC. (US) | 1995-09-21 | — | — | WO | disclosed |
| US-4566899-A | Selective herbicidal benzylcarbamoylpyridine derivatives | RHONE-POULENC AGROCHIMIE (FR) | 1986-01-28 | — | — | US | disclosed |
| US-4566899-A | Selective herbicidal benzylcarbamoylpyridine derivatives | RHONE-POULENC AGROCHIMIE (FR) | 1986-01-28 | — | — | US | disclosed |
| EP-0112262-A1 | Benzylcarbamoylpyridine derivatives | RHONE-POULENC AGROCHIMIE (FR) | 1984-06-27 | — | — | EP | disclosed |
| EP-0112262-A1 | Benzylcarbamoylpyridine derivatives | RHONE-POULENC AGROCHIMIE (FR) | 1984-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190127337-A1 | HETEROCYCLIC CARBOXYLIC ACID AMIDE LIGAND AND APPLICATIONS THEREOF IN COPPER CATALYZED COUPLING REACTION OF ARYL HALOGENO SUBSTITUTE | AOC1, AOC2, AOC3 | HTT 2764/4885KMT2A 1850/4885KDR 1005/4885 |
| US-10759765-B2 | Heterocyclic carboxylic acid amide ligand and applications thereof in copper catalyzed coupling reaction of aryl halogeno substitute | AOC1, AOC2, AOC3 | HTT 2764/4885KMT2A 1850/4885KDR 1005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.